Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 2:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1201–1224 of 7,893 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Presbyopia
Interventions: Raindrop Near Vision Inlay; Device
Lead sponsor: Eye Center of North Florida; Other
Eligibility: 41 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Panama City, Florida

Conditions: Type II Diabetes Mellitus, Obesity
Interventions: Gastric Band, Gastric Sleeve, Gastrostomy Tube; Procedure
Lead sponsor: East Carolina University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Contraception
Interventions: AMPHORA; Drug
Lead sponsor: Evofem Inc.; Industry
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 1,384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 87
States / cities: Mobile, Alabama • Chandler, Arizona • Mesa, Arizona + 67 more

Conditions: Lung Cancer, Lymphoma
Interventions: DNA analysis, RNA analysis, gene expression analysis, polymorphism analysis, biologic sample preservation procedure, flow cytometry, medical chart review; Genetic · Other
Lead sponsor: AIDS Malignancy Consortium; Network
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 14
States / cities: La Jolla, California • Los Angeles, California • Washington D.C., District of Columbia + 9 more

Conditions: Adult ALL
Interventions: V-TARGET intervention; Device
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Prematurity
Interventions: Pacifier-Activated-Lullaby system (PAL).; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 34 Weeks to 36 Weeks
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sleep, Sleep Deprivation, Cognitive Change
Interventions: Nap Practitioners, Shoonya Meditation; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer
Interventions: Atezolizumab, Placebo, Doxorubicin, Cyclophosphamide, Paclitaxel, Trastuzumab, Pertuzumab, Trastuzumab Emtansine; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 454 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: Kansas City, Missouri • New York, New York • Nashville, Tennessee

Conditions: Diet Modification
Interventions: Full Plate Diet; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma, Rhabdomyosarcoma, Non-rhabdomyosarcoma
Interventions: alemtuzumab, fludarabine, sirolimus, Busulfan, melphalan, stem cells, CliniMACS; Drug · Biological · Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 2 Years to 21 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Peripheral Artery Disease
Interventions: Walking Program: Internet-based, Walking Program: Telehealth-based; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Birmingham, Alabama • Palo Alto, California • Aurora, Colorado

Conditions: Distracted Driving, Injury Prevention, Behavioral Economics
Interventions: Driving Tips, Standard Feedback, Assigned Focus Area Feedback, Study Dashboard (Standard), Study Dashboard (focused), UBI-like Behavioral Incentive, Sef-Chosen Focus Area Feedback; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 1,449 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Child Behavior Disorders
Interventions: Control - Provider Medication Alert Only, Intervention - Alert + CAP Review AND Enhanced BH Access; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 3 Years to 17 Years
Enrollment: 733 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 4
States / cities: Aurora, Colorado • Columbus, Ohio • Portland, Oregon + 1 more

Conditions: Venous Leg Ulcer
Interventions: allo-APZ2-CVU, Placebo; Drug
Lead sponsor: RHEACELL GmbH & Co. KG; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 4
States / cities: Hialeah, Florida • Miami, Florida • Boston, Massachusetts + 1 more

Conditions: Perinatal Depression, Perinatal Anxiety, Prenatal Stress
Interventions: Patient Navigation, Adapted Cognitive-Behavioral Therapy; Behavioral
Lead sponsor: Children's National Research Institute; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: High-risk Non-muscle Invasive Bladder Cancer
Interventions: Pembrolizumab, BCG; Biological
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 1,397 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2034
U.S. locations: 44
States / cities: Anchorage, Alaska • Phoenix, Arizona • Tucson, Arizona + 39 more

Conditions: Depression, Palliative Care, Cancer, Mental Disorder
Interventions: Methylphenidate, Placebo, Selective Serotonin Uptake Inhibitor (SSRI); Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Neck Pain
Interventions: Home Exercise Program, Patient advice, encouragement, and education, Thrust Manipulation, Non-thrust Mobilizations; Other
Lead sponsor: Youngstown State University; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Youngstown, Ohio

Conditions: Cognition, Cognition Disorders, Cognition - Other, Dementia, Alzheimer Disease, Memory, Neurocognition
Interventions: Voice-based Cognitive Testing; Diagnostic Test
Lead sponsor: The Neurology Center of Southern California; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Carlsbad, California

Conditions: Neonatology
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: Not listed
Enrollment: 395 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Colonic Neoplasms
Interventions: Not listed
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 11
States / cities: Los Angeles, California • Urbana, Illinois • Boston, Massachusetts + 8 more

Conditions: Type II Diabetes
Interventions: Tablet Computer; Device
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Vaccine Exposure During Pregnancy
Interventions: Data collection; Other
Lead sponsor: VBI Vaccines Inc.; Industry
Eligibility: Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2032
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Dance/movement therapy (eMove); Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

A Study Raindrop Near Vision Inlay in Presbyopes Implanted in Corneal Pockets

Metabolomics of Roux-en-Y Gastric Bypass (RYGB) With Gastrostomy

AMP002 Phase III Contraceptive Study

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes

A Clinical Trial of A Pacifier-Activated Music Player

Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators

A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer

Full Plate Diet Study

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease

A Randomized Field Trial of Smartphone-based Feedback to Encourage Safe Driving

Safer Use of Antipsychotics in Youth

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)

The DC Mother-Infant Behavioral Wellness Program

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

Thrust Manipulation vs. Non-thrust Mobilizations for Mechanical Neck Pain

Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan

The Impact of Non-Routine Events on Neonatal Safety

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration

PREHEVBRIO Pregnancy Outcomes Registry

eMove - Dance/Movement Therapy Study